210 related articles for article (PubMed ID: 31079216)
1. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
[TBL] [Abstract][Full Text] [Related]
2. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
[TBL] [Abstract][Full Text] [Related]
3. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptors: binding properties, transduction pathways, and structure.
Vincent JP
Cell Mol Neurobiol; 1995 Oct; 15(5):501-12. PubMed ID: 8719037
[TBL] [Abstract][Full Text] [Related]
6. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
[TBL] [Abstract][Full Text] [Related]
7. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
8. Functional activity of new C-terminal cyclic-neurotensin fragment analogs.
Akunne HC; Darling S; Zoski K; Sefler AM; He JX; Sawyer TK; Pugsley TA; Cody WL
Neuropeptides; 1996 Jun; 30(3):213-8. PubMed ID: 8819144
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
[TBL] [Abstract][Full Text] [Related]
10. Activation of neurotensin receptors and purinoceptors in human colonic adenocarcinoma cells detected with the microphysiometer.
Richards M; van Giersbergen P; Zimmermann A; Lesur B; Hoflack J
Biochem Pharmacol; 1997 Oct; 54(7):825-32. PubMed ID: 9353137
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
12. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
[TBL] [Abstract][Full Text] [Related]
13. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
[TBL] [Abstract][Full Text] [Related]
14. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.
Fanelli R; Besserer-Offroy É; René A; Côté J; Tétreault P; Collerette-Tremblay J; Longpré JM; Leduc R; Martinez J; Sarret P; Cavelier F
J Med Chem; 2015 Oct; 58(19):7785-95. PubMed ID: 26348111
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
Heyl DL; Sefler AM; He JX; Sawyer TK; Wustrow DJ; Akunne HC; Davis MD; Pugsley TA; Heffner TG; Corbin AE
Int J Pept Protein Res; 1994 Sep; 44(3):233-8. PubMed ID: 7822099
[TBL] [Abstract][Full Text] [Related]
17. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
[TBL] [Abstract][Full Text] [Related]
18. Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT
Previti S; Vivancos M; Rémond E; Beaulieu S; Longpré JM; Ballet S; Sarret P; Cavelier F
Front Chem; 2020; 8():406. PubMed ID: 32582624
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine.
Lundquist JT; Dix TA
J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
Mascarin A; Valverde IE; Vomstein S; Mindt TL
Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
